<DOC>
	<DOCNO>NCT00984126</DOCNO>
	<brief_summary>This trial conduct Asia , Europe , Japan , Oceania , North America South America . The aim trial investigate safety efficacy turoctocog alfa ( N8 ) Haemophilia A patient . The trial extension trial NN7008-3543 ( start : March 2009 , stop : September 2011 ) NN7008-3545 ( start : May 2010 , stop : November 2011 ) pharmacokinetic trial NN7008-3600 ( start : November 2010 , stop : October 2011 ) , NN7008-3893 ( start : June 2011 , stop : September 2011 ) NN7008-4015 ( start : August 2012 , stop : March 2013 ) .</brief_summary>
	<brief_title>Safety Efficacy Turoctocog Alfa ( N8 ) Prevention On-demand Treatment Bleeding Episodes Subjects With Haemophilia A : An Extension Trials NN7008-3543 , NN7008-3545 , NN7008-3600 , NN7008-3893 NN7008-4015</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Informed Consent obtain trialrelated activity Completion trial NN70083543 paediatric trial NN70083545 Japanese trial NN70083600 pharmacokinetic trial NN70083893 NN70084015 Previous participation current trial ( define withdrawal ) withdrawn subject NN70083522 , NN70083543 , NN70083545 , NN70083600 , NN70083893 NN70084015 administration trial product</criteria>
	<gender>Male</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>